A detailed history of Trust Point Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Trust Point Inc. holds 20,292 shares of ABT stock, worth $2.39 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
20,292
Previous 20,911 2.96%
Holding current value
$2.39 Million
Previous $2.17 Billion 6.47%
% of portfolio
0.17%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$100.07 - $118.13 $61,943 - $73,122
-619 Reduced 2.96%
20,292 $2.31 Billion
Q2 2024

Jul 24, 2024

SELL
$100.73 - $112.44 $119,465 - $133,353
-1,186 Reduced 5.37%
20,911 $2.17 Billion
Q1 2024

Apr 19, 2024

SELL
$109.52 - $120.96 $392,300 - $433,278
-3,582 Reduced 13.95%
22,097 $2.51 Billion
Q4 2023

Jan 23, 2024

BUY
$90.19 - $110.4 $2.32 Million - $2.83 Million
25,679 New
25,679 $2.83 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Trust Point Inc. Portfolio

Follow Trust Point Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Point Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trust Point Inc. with notifications on news.